Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Karin Norvin Nilsson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13776782

LIQUID PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDE

IPC classification:
A61K 38/37, A61K 31/4184, A61P 7/04
Applicant:
Novo Nordisk Health Care AG
Agent:
Karin Norvin Nilsson, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN

Please Sign in to use this feature